Skip to content

TOP NEWS PRESS

  • International
  • Business
  • Technology
  • Healthcare

Business

Dyslipidemia Therapeutics Market is projected to record 2.5% CAGR through 2028
Business Healthcare

Dyslipidemia Therapeutics Market is projected to record 2.5% CAGR through 2028

January 19, 2021 Manoj

According to a recently released Fact.MR study, revenues from dyslipidemia therapeutics market surpassed US$ 36 billion in 2018. Low-density lipoproteins held approximately two-thirds of revenues from […]

Contract Pharmaceutical Fermentation Services Market is likely to contribute over nearly US$ 2,400 million by value by 2026-end
Business Healthcare

Contract Pharmaceutical Fermentation Services Market is likely to contribute over nearly US$ 2,400 million by value by 2026-end

January 19, 2021 Manoj

The contract pharmaceutical fermentation services market is anticipated to continue its steady growth on back of the evolving use of fermentation techniques to develop active […]

Business Healthcare

The Gut Disorders Treatment Market to be at the discretion of growth between 2018 and 2028

December 21, 2020 Manoj

Gut plays a vital role in the food processing system that includes the interaction between the immunity and diet. Gut disorders are extremely common, and […]

Business Healthcare

 The Fixed-Dose Combination Drugs Market to think beyond economic downturn from 2021 onwards

December 21, 2020 Manoj

Fixed-Dose Combination Drugs refer to the combination of different drugs in a capsule or a tablet. There are mainly two types of fixed-dose combination drugs- […]

Recent Posts
  • Self-Administered Medication Market to See Huge Growth by 2026 | Companies Abbott Laboratories, Purdue Pharma LP, Sanofi S.A., Pfizer, Inc.
  • Peptide Based Metabolic Disorders Therapeutics Market is anticipated to show a robust growth rate during the forecasted period of 2017-2022 and expected to reflect a value more than US$ 8 Bn
  • North America Peptide Based Hematological Disorders Therapeutics Market is the most attractive market, growing at a robust CAGR over the assessment period 2017 to 2022
  • Top Key Companies of Peptide Based Gastrointestinal Disorders Therapeutics Market are Shire plc, Ironwood Pharmaceuticals, Inc., Astellas Pharma Inc.
  • Peptide Based Cardiovascular Therapeutics Market to See Huge Growth by 2022 | Companies AstraZeneca, plc, Corden Pharma GmbH, Ipsen S.A
Categories
  • Business
  • Healthcare
  • Technology
Powered By: WordPress | Theme: newsbook By OdieThemes